Literature DB >> 20019130

Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.

Carla Bizzarri1, Antonello E Rigamonti, Antonella Luce, Marco Cappa, Silvano G Cella, Jenny Berini, Alessandro Sartorio, Eugenio E Müller, Alessandro Salvatoni.   

Abstract

BACKGROUND AND AIMS: Ghrelin is an orexigenic 28-amino acid peptide produced by the stomach. Circulating ghrelin levels rise shortly before and fall shortly after every meal. Peptide YY (PYY), an anorexigenic 36-amino acid peptide, is secreted primarily from the intestinal mucosa of the ileum and large intestine. Plasma PYY levels begin to rise within 15 min after starting to eat and plateau within approximately 90 min, remaining elevated for up to 6 h. Recently, some studies have tried to evaluate the potential role of ghrelin and PYY in the hyperphagia of patients with Prader-Willi syndrome (PWS). While hyperghrelinemia is well characterized in PWS, conflicting results have been reported for PYY. The aim of the study was to investigate ghrelin and PYY responses to a standard liquid high-fat meal in children with PWS. PATIENTS AND METHODS: Circulating levels of total ghrelin and PYY levels were assayed by RIA after overnight fasting and 45, 60, 90, and 180 min following a standard meal (Ensure 6 ml/kg) in 16 patients with PWS (11 boys and five girls, aged 4.6-10.7 years, including ten receiving 0.02 mg/kg per day rhGH for 2-18 months; body mass index (BMI) z-score: 0.6+/-0.2 and 1.6+/-0.5 for children treated or not treated with rhGH respectively), ten obese (eight boys and two girls, aged 9.2-15.6 years; BMI z-score: 2.4+/-0.2, i.e. BMI >97th centile for chronological age and sex) subjects, and 16 normal-weight controls (five boys and 11 girls, aged 5.8-17.3 years; BMI z-score: 0.6+/-0.2).
RESULTS: PWS children showed higher fasting levels of ghrelin than obese and lean controls. Postprandial ghrelin drop was more pronounced in PWS than in the other study groups. No significant difference on fasting levels of PYY was found among groups. PWS showed a higher postprandial PYY rise than obese and lean controls. PWS patients treated and not treated with GH showed similar fasting and postprandial levels of ghrelin and PYY. Fasting PYY levels correlated negatively (P<0.05; r=-0.68) with those of ghrelin only in PWS.
CONCLUSIONS: The results of this study confirm fasting hyperghrelinemia in PWS. Since in PWS adults an impaired postprandial suppression of plasma ghrelin was previously reported to be associated with a blunted postprandial PYY response, the finding of a meal-induced decrease and increase in ghrelin and PYY levels respectively in PWS children would imply that the regulation of appetite/satiety of these peptides is operative during childhood, and it progressively deteriorates and vanishes in adulthood when hyperphagia and obesity worsen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019130     DOI: 10.1530/EJE-09-1033

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  21 in total

1.  Oligoclonal antibody targeting ghrelin increases energy expenditure and reduces food intake in fasted mice.

Authors:  Joseph S Zakhari; Eric P Zorrilla; Bin Zhou; Alexander V Mayorov; Kim D Janda
Journal:  Mol Pharm       Date:  2011-12-23       Impact factor: 4.939

2.  CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells.

Authors:  Eran Gershon; Wylie W Vale
Journal:  Obesity (Silver Spring)       Date:  2013-09-10       Impact factor: 5.002

Review 3.  Review of Prader-Willi syndrome: the endocrine approach.

Authors:  Ryan Heksch; Manmohan Kamboj; Kathryn Anglin; Kathryn Obrynba
Journal:  Transl Pediatr       Date:  2017-10

4.  Drug-induced sleep endoscopy in children with Prader-Willi syndrome.

Authors:  Ming-Chin Lan; Yen-Bin Hsu; Ming-Ying Lan; Tsan-Jen Chiu; Tung-Tsun Huang; Shi-Bing Wong; Yu-Cheng Chen; Li-Ping Tsai
Journal:  Sleep Breath       Date:  2016-04-08       Impact factor: 2.816

5.  Approach to the child with prader-willi syndrome.

Authors:  Jennifer L Miller
Journal:  J Clin Endocrinol Metab       Date:  2012-11       Impact factor: 5.958

Review 6.  The ghrelin/GOAT/GHS-R system and energy metabolism.

Authors:  Chung Thong Lim; Blerina Kola; Márta Korbonits
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

Review 7.  Translational neuroscience approaches to hyperphagia.

Authors:  Mario Perello; Jen-Chieh Chuang; Michael M Scott; Michael Lutter
Journal:  J Neurosci       Date:  2010-09-01       Impact factor: 6.167

Review 8.  Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Authors:  Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

9.  A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome.

Authors:  J L Miller; C H Lynn; J Shuster; D J Driscoll
Journal:  J Hum Nutr Diet       Date:  2012-10-18       Impact factor: 3.089

10.  Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome.

Authors:  Pinar Gumus Balikcioglu; Metin Balikcioglu; Michael J Muehlbauer; Jonathan Q Purnell; David Broadhurst; Michael Freemark; Andrea M Haqq
Journal:  J Clin Endocrinol Metab       Date:  2015-08-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.